R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.3 Million USD | 105.73% |
| 2022 | -57.6 Million USD | -165.98% |
| 2021 | 87.3 Million USD | -24.22% |
| 2020 | 115.2 Million USD | 860.0% |
| 2019 | 12 Million USD | 126.49% |
| 2018 | -45.3 Million USD | 22.96% |
| 2017 | -58.8 Million USD | -133.21% |
| 2016 | 177.07 Million USD | 310.16% |
| 2015 | -84.25 Million USD | -5.82% |
| 2014 | -79.62 Million USD | -161.21% |
| 2013 | 130.08 Million USD | 208.64% |
| 2012 | -119.74 Million USD | -510.57% |
| 2011 | 29.16 Million USD | 131.13% |
| 2010 | 12.61 Million USD | -13.52% |
| 2009 | 14.59 Million USD | 1073.77% |
| 2008 | 1.24 Million USD | 60.59% |
| 2007 | 774 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -19.9 Million USD | -161.84% |
| 2024 Q1 | -35.1 Million USD | -2607.14% |
| 2024 Q2 | -7.6 Million USD | 78.35% |
| 2023 Q4 | 1.4 Million USD | 7.69% |
| 2023 Q1 | 300 Thousand USD | 100.81% |
| 2023 Q3 | 1.3 Million USD | 333.33% |
| 2023 Q2 | 300 Thousand USD | 0.0% |
| 2023 FY | 3.3 Million USD | 105.73% |
| 2022 Q3 | -29.5 Million USD | -44.61% |
| 2022 FY | -57.6 Million USD | -165.98% |
| 2022 Q4 | -37.1 Million USD | -25.76% |
| 2022 Q1 | 29.4 Million USD | -18.33% |
| 2022 Q2 | -20.4 Million USD | -169.39% |
| 2021 Q1 | 25.8 Million USD | -67.18% |
| 2021 Q2 | 18.4 Million USD | -28.68% |
| 2021 Q3 | 17 Million USD | -7.61% |
| 2021 Q4 | 36 Million USD | 111.76% |
| 2021 FY | 87.3 Million USD | -24.22% |
| 2020 Q3 | 5.2 Million USD | -65.56% |
| 2020 FY | 115.2 Million USD | 860.0% |
| 2020 Q1 | 18.2 Million USD | 133.33% |
| 2020 Q2 | 15.1 Million USD | -17.03% |
| 2020 Q4 | 78.6 Million USD | 1411.54% |
| 2019 FY | 12 Million USD | 126.49% |
| 2019 Q1 | 200 Thousand USD | 103.51% |
| 2019 Q3 | 9.2 Million USD | 276.92% |
| 2019 Q2 | -5.2 Million USD | -2700.0% |
| 2019 Q4 | 7.8 Million USD | -15.22% |
| 2018 Q3 | -13.4 Million USD | -362.07% |
| 2018 Q2 | -2.9 Million USD | 87.55% |
| 2018 FY | -45.3 Million USD | 22.96% |
| 2018 Q1 | -23.3 Million USD | 42.04% |
| 2018 Q4 | -5.7 Million USD | 57.46% |
| 2017 Q3 | -3.6 Million USD | 46.27% |
| 2017 Q1 | -8.3 Million USD | -163.23% |
| 2017 FY | -58.8 Million USD | -133.21% |
| 2017 Q4 | -40.2 Million USD | -1016.67% |
| 2017 Q2 | -6.7 Million USD | 19.28% |
| 2016 Q3 | 37.33 Million USD | 191.52% |
| 2016 Q4 | 13.12 Million USD | -64.84% |
| 2016 Q1 | 167.4 Million USD | 2973.31% |
| 2016 FY | 177.07 Million USD | 310.16% |
| 2016 Q2 | -40.79 Million USD | -124.37% |
| 2015 Q1 | -30.44 Million USD | -72.48% |
| 2015 Q4 | 5.44 Million USD | 116.52% |
| 2015 Q3 | -32.97 Million USD | -25.42% |
| 2015 Q2 | -26.28 Million USD | 13.65% |
| 2015 FY | -84.25 Million USD | -5.82% |
| 2014 Q4 | -17.65 Million USD | -284.77% |
| 2014 Q3 | 9.55 Million USD | 156.87% |
| 2014 Q2 | -16.79 Million USD | 69.3% |
| 2014 Q1 | -54.72 Million USD | -956.92% |
| 2014 FY | -79.62 Million USD | -161.21% |
| 2013 Q1 | -26.46 Million USD | 78.56% |
| 2013 FY | 130.08 Million USD | 208.64% |
| 2013 Q3 | -37.57 Million USD | -120.01% |
| 2013 Q4 | 6.38 Million USD | 117.0% |
| 2013 Q2 | 187.73 Million USD | 809.36% |
| 2012 Q2 | -578 Thousand USD | -138.71% |
| 2012 Q3 | 2.75 Million USD | 576.64% |
| 2012 Q1 | 1.49 Million USD | -88.67% |
| 2012 Q4 | -123.41 Million USD | -4579.49% |
| 2012 FY | -119.74 Million USD | -510.57% |
| 2011 Q3 | 7.27 Million USD | -15.0% |
| 2011 Q4 | 13.18 Million USD | 81.31% |
| 2011 Q1 | 160 Thousand USD | -97.11% |
| 2011 FY | 29.16 Million USD | 131.13% |
| 2011 Q2 | 8.55 Million USD | 5245.63% |
| 2010 FY | 12.61 Million USD | -13.52% |
| 2010 Q2 | 3.91 Million USD | 1148.09% |
| 2010 Q4 | 5.52 Million USD | 93.42% |
| 2010 Q3 | 2.85 Million USD | -27.07% |
| 2010 Q1 | 314 Thousand USD | -93.85% |
| 2009 FY | 14.59 Million USD | 1073.77% |
| 2009 Q2 | -557 Thousand USD | 12.7% |
| 2009 Q3 | 4.27 Million USD | 866.61% |
| 2009 Q4 | 5.1 Million USD | 19.58% |
| 2009 Q1 | -638 Thousand USD | -23.64% |
| 2008 Q3 | 2.35 Million USD | 0.0% |
| 2008 Q4 | -516 Thousand USD | -121.93% |
| 2008 FY | 1.24 Million USD | 60.59% |
| 2007 FY | 774 Thousand USD | 0.0% |
| 2000 Q4 | -37.1 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 22.57 Million USD | 85.385% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 99.79% |
| Sharecare, Inc. | -128.49 Million USD | 102.568% |
| Progyny, Inc. | 62.03 Million USD | 94.681% |
| Aclarion, Inc. | -4.91 Million USD | 167.191% |
| CareMax, Inc. | -683.34 Million USD | 100.483% |
| Simulations Plus, Inc. | 9.95 Million USD | 66.847% |
| CareCloud, Inc. | -48.67 Million USD | 106.78% |
| Forian Inc. | 11.1 Million USD | 70.288% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | 161.615% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | 161.615% |
| Minerva Surgical, Inc. | -34.11 Million USD | 109.674% |
| Omnicell, Inc. | -20.37 Million USD | 116.199% |
| Definitive Healthcare Corp. | -202.38 Million USD | 101.631% |
| Zhongchao Inc. | -11.33 Million USD | 129.111% |
| Accolade, Inc. | -99.8 Million USD | 103.306% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | 117.65% |
| Ontrak, Inc. | -27.92 Million USD | 111.819% |
| SOPHiA GENETICS SA | -78.98 Million USD | 104.178% |
| Spok Holdings, Inc. | 15.66 Million USD | 78.935% |
| Privia Health Group, Inc. | 23.07 Million USD | 85.701% |
| EUDA Health Holdings Limited | -10.03 Million USD | 132.87% |
| HeartBeam, Inc. | -14.63 Million USD | 122.543% |
| GeneDx Holdings Corp. | -175.76 Million USD | 101.877% |
| TruBridge, Inc. | -45.78 Million USD | 107.207% |
| Nutex Health, Inc. | -45.78 Million USD | 107.207% |
| Renalytix Plc | -33.45 Million USD | 109.864% |
| Sharecare, Inc. | -128.49 Million USD | 102.568% |
| Health Catalyst, Inc. | -118.14 Million USD | 102.793% |
| 10x Genomics, Inc. | -255.09 Million USD | 101.294% |
| GoodRx Holdings, Inc. | -8.86 Million USD | 137.212% |
| SCWorx Corp. | -3.98 Million USD | 182.891% |
| Schrödinger, Inc. | 40.72 Million USD | 91.896% |
| HealthEquity, Inc. | 55.71 Million USD | 94.077% |
| HealthStream, Inc. | 15.21 Million USD | 78.308% |
| MSP Recovery, Inc. | -56.34 Million USD | 105.856% |
| Augmedix, Inc. | -19.17 Million USD | 117.213% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 102.134% |
| Ontrak, Inc. | -27.92 Million USD | 111.819% |
| SHL Telemedicine Ltd. | -7.05 Million USD | 146.769% |
| CareCloud, Inc. | -48.67 Million USD | 106.78% |
| Premier, Inc. | 119.54 Million USD | 97.24% |
| Certara, Inc. | -55.35 Million USD | 105.961% |
| GeneDx Holdings Corp. | -175.76 Million USD | 101.877% |
| OneMedNet Corporation | -23.2 Million USD | 114.221% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 102.134% |
| EUDA Health Holdings Limited | -10.03 Million USD | 132.87% |
| HeartBeam, Inc. | -14.63 Million USD | 122.543% |
| CareCloud, Inc. | -48.67 Million USD | 106.78% |
| Mangoceuticals, Inc. | -9.21 Million USD | 135.821% |
| CareMax, Inc. | -683.34 Million USD | 100.483% |
| Healthcare Triangle, Inc. | -12.33 Million USD | 126.744% |
| National Research Corporation | 30.97 Million USD | 89.345% |
| Aclarion, Inc. | -4.91 Million USD | 167.191% |
| OptimizeRx Corporation | -17.56 Million USD | 118.786% |